Pristiq vs. Effexor
The Carlat Psychiatry Report, Volume 6, Number 4, April 2008
https://www.thecarlatreport.com/newsletter-issue/tcprv6n4/
Issue Links: Learning Objectives | Editorial Information
Topics: Antidepressants
Daniel Carlat, MD
After many years of trying, Wyeth finally received FDA approval for its new antidepressant, Pristiq (desvenlafaxine). Don’t get too excited, though – Pristiq is simply the active metabolite of Effexor and it’s unclear whether it adds anything of value to our current quiver of antidepressants.
You can't view details of this content, please login or buy subscription here
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.